期刊文献+

EZH2蛋白在卵巢上皮性肿瘤中的表达及其作用 被引量:6

Expression of EZH2 protein and its role in ovarian epithelial tumor
原文传递
导出
摘要 目的观察EZH2在不同卵巢组织中的表达,探讨其在肿瘤发展中可能发挥的作用。方法采用免疫组织化学染色检测15例正常卵巢组织、32例卵巢良性肿瘤、28例卵巢交界性肿瘤及50例卵巢癌中EZH2蛋白的表达,其中15例正常卵巢组织、23例卵巢良性肿瘤、23例交界性肿瘤及25例卵巢癌行RT-PCR检测。结果 1EZH2蛋白在卵巢癌细胞核中的表达明显高于正常卵巢组织(P<0.01)、卵巢良性肿瘤(P<0.01)及交界性肿瘤(P<0.05),且与肿瘤的分级和分期具有相关性(P<0.01,P<0.05);2 EZH2蛋白在卵巢肿瘤组织的细胞质中亦有表达,且良性肿瘤和交界性肿瘤中的表达高于卵巢癌(P均<0.05);3 EZH2蛋白在卵巢癌细胞核中的表达与Ki-67呈正相关性(r=0.40,P<0.01)。结论卵巢肿瘤组织细胞核及细胞质中均有EZH2蛋白的表达,且卵巢癌细胞核中EZH2蛋白的表达与肿瘤的分期及分级具有相关性,并参与细胞增殖。 Objective To explore the expression of EZH2 protein in different epithelial ovarian tumors and its possible role in tumor development.Methods Immunohistochemistry was used to detect EZH2 protein expression in 15 normal ovarian tissues,32 ovarian benign tumors,28 ovarian borderline tumors and 50 primary epithelial ovarian cancers. Real-time quantitative PCR (RT-PCR)was used to detect EZH2 mRNA expression in 15 normal ovarian tissues,23 ovarian benign tumors,23 borderline tumors and 25 epithelial ovarian cancers.Results ① EZH2 expressed highly in nucleus in epithelial ovarian cancers compared with normal ovarian tissue (P 〈0.01),benign tumor (P 〈0.01)and borderline tumor (P 〈0.05).EZH2 expression was significantly correlated with grade and staging of tumor in epithelial ovarian cancers (P 〈0.01,P 〈0.05).② EZH2 protein expressed in cytoplasm in ovarian tumor,and it expressed highly in benign ovarian tumor and borderline tumor compared with epithelial ovarian cancers (P 〈0.05 ).③ The nuclear expression of EZH2 protein in epithelial ovarian cancers was positively correlated with Ki-67 (r =0.40,P 〈0.01).Conclusion EZH2 protein expresses in both nucleus and cytoplasm in ovarian tumors,and its elevated nuclear expression in epithelial ovarian cancers is associated with not only staging and grade of tumor,but also cell proliferation.
出处 《山东大学学报(医学版)》 CAS 北大核心 2015年第2期65-70,共6页 Journal of Shandong University:Health Sciences
基金 国家自然科学基金(81172482) 中国博士后科学基金(2012M520201)
关键词 卵巢肿瘤 EZH2 蛋白 KI-67 细胞质 EZH2 mRNA Ovarian cancer EZH2 protein EZH2 mRNA Cytoplasm
  • 相关文献

参考文献16

  • 1Jemal A, Siegel R, Xu JQ, et al. Cancer statistics[J]. Cancer J Clin, 2010, 60(5): 277-300.
  • 2毛晓韵,姚凡,金锋.EZH2与乳腺癌发生发展的关系[J].中华肿瘤防治杂志,2010,17(2):149-152. 被引量:7
  • 3Min J, Zaslavsky A, Fedele G, et al. An oncogene-tumor suppressor cascade drives metastatic prostate cancer by coordinately activating Ras and nuclear factor-κB[J]. Nat Med, 2010, 16(3): 286-294.
  • 4Moore HM, Gonzalez ME, Toy KA, et al. EZH2 inhibition decreases p38 signaling and suppresses breast cancer motility and metastasis[J]. Breast Cancer Research and Treatment, 2013, 138(3): 741-752.
  • 5Chang CJ, Hung MC. The role of EZH2 in tumor progression[J]. Br J Cancer, 2012, 106(2): 243-247.
  • 6褚金曼,杜咏梅,骆树瑜,李蕊,董瑞.EZH2和Ki-67蛋白在腺样囊性癌中的表达及其临床意义[J].中国肿瘤临床,2014,41(5):311-314. 被引量:1
  • 7Ren G, Baritaki S, Marathe H, et al. Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer[J]. Cancer Research, 2012, 72(12): 3091-3104.
  • 8Au SL, Wong CC, Lee JM, et al. Enhancer of zeste homolog 2 epigenetically silences multiple tumor suppressor microRNAs to promote liver cancer metastasis[J]. Hepatology, 2012, 56(2): 622-631.
  • 9Crea F, Fornaro L, Bocci G, et al. EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis[J]. Cancer Metastasis Reviews, 2012, 31(3-4): 753-761.
  • 10Xu L, Beckebaum S, Iacob S, et al. MicroRNA-101 inhibits human hepatocellular Carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity[J]. Journal of Hepatology, 2014, 60(3): 590-598.

二级参考文献29

  • 1Bertucci F, Birnbaum D. Reasons for breast cancer heterogeneity[J]. J Biol,2008,7(2) :6.
  • 2Chen H, Rossier C, Antonarakis S E. Cloning of a human hom olog of the Drosophila enhancer of zeste gene (EZH2) that maps to chromosome 21q22.2[J]. Genomics,1996,38(38):30-37.
  • 3Kahn T G, Schwartz Y B, Dellino G I, et al. Polycomb complexes and the propagation of the methylation mark at the Drosophila ubx gene[J]. J Biol Chem,2006,281(39) :29064-29075.
  • 4Ezhkova E, Pasolli H A, Parker J S, et al. Ezh2 orchestrates gene expression for the stepwise differentiation of tissue-specific stem cells[J]. Cell,2009,136(6) :1122-1135.
  • 5Richter G H, Plehm S, Fasan A, et al. EZH2 is a mediator of EWS/FLI1 driven tumor growth and metastasis blocking endothelial and neuro-ectodermal differentiation[J]. Proc Natl Acad Sci U S A,2009,106(13):5324-5329.
  • 6Cardoso C, Timsit S, Villard L, et al. Specific interaction between the XNP/ATR-X gene product and the SET domain of the humanEZH2 protein[J]. Hum Mol Genet,1998,7(4):679-684.
  • 7Cardoso C, Mignon C, Hetet G, et al. The human EZH2 gene: genomic organisation and revised mapping in 7q35 within the critical region for malignant myeloid disorders[J]. Eur J Hum Genet,2000,8(3) :174-180.
  • 8Arisan S, Buyuktuncer E D, Palavan-Unsal N, et al. Increased expression of EZH2, a polycomb group protein, in bladder carcinoma[J]. Urol Int,2005,75(3):252-257.
  • 9Qian C, Zhou M M. SET domain protein lysine methyltransferases: Structure, specificity and catalysis[J]. Cell Mol Life Sci,2006,63(23) :2755-2763.
  • 10Aravind L, Iyer L M. Provenance of SET domain histone methyltransferases through duplication of a simple structural unit[J]. Cell Cycle, 2003,2 (4) : 369-376.

共引文献6

同被引文献85

  • 1方静,薛艳,周党侠,苟文丽.EZH2基因在宫颈癌中的表达及其意义[J].西安交通大学学报(医学版),2011,32(6):758-760. 被引量:10
  • 2谢丽,安瑞芳,王姝,薛艳.Ki-67蛋白在妊娠滋养细胞疾病中表达的意义[J].现代肿瘤医学,2007,15(7):1001-1003. 被引量:3
  • 3Margueron R, Reinberq D. The Polycomb complex PRC2 and its mark in life[J]. Nature, 2011,469(7330) :343-349. DOI: 10. 1038/nature09784.
  • 4Cardoso C, Mignon C, Hetet G, et al. The human EZH2 gene : genomic organisatin and revised mapping in 7q35 within the criti- cal region for malignant myeloid disorders[J]. Eur J Hum Genet- ics,2000,8(3) :174-180. DOI:10. 1038/sj. ejhg. 5200439.
  • 5Margueron R,Li G,Sarma K,et al. EZH1 and EZH2 maintain re- pressive chromatin throughe different mechanisms [ J ]. Mol Cell, 2008,32(4) :503-518. DOI: 10. 1016/j. molCel. 2008.11. 004.
  • 6Hillier LW, Fulton RS, Fulton LA, et al. The DNA sequence of human chromosome 7 [ J ]. Nature, 2003,10 ; 424 ( 6945 ) : 157- 164. DOI:10. 1038/nature01782.
  • 7Kim W, Bird GH, Neff T, et al. Target disruption of the EZH2- EED complex inhibits EZH2-dependent cancer [ J ]. Nature Chemical Biology, 2013, 9 (10) : 643-650. DOI: 10. 1038/ nchembio. 1331.
  • 8Lessard J1, Sauvageau G. Polycomb group genes as epigenetic regulators of normal and leukemic hemopoiesis[ J]. Exp Hematol, 2003,31 ( 7 ) :567-585. DOI. 10. 1016/S0301-472X ( 03 ) 00081 - X.
  • 9Hock H. A complex polycomb issue: the two faces EZH2 in canc- er[J]. Genes Dev, 2012,26(8) :751-755. DOI: 10. ll01/gad.191163. 112.
  • 10Coe BP, Thu KL, Aviel-Ronen S, et ol. Genomic deregulation of the E2F/Rb pathway leads to activation of the oncogene EZH2 in small cell lung cancer[J]. PLoS One, 2013,8(8) : e71670. DOI: 10. 1371/joum01. pone. 0071670. eCollection 2013.

引证文献6

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部